| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Aquilo Capital Management, LLC is a 10% Owner at PALVELLA THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $454.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2020 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 264,933 | $18.80 | $4,981,259.54 | -3.2% | |
| Nov 9, 2020 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 125,900 | $13.77 | $1,734,071.06 | -2.9% | |
| Nov 6, 2020 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 174,100 | $14.09 | $2,452,947.51 | -1.3% | |
| Jul 21, 2020 | PVLA Palvella Therapeutics, Inc. | 10% Owner | Sell | 1,900,000 | $2.95 | $5,605,000.00 | -34.1% |